Bertin Technologies accumulated turnover in 2008: € 54.8M.

Bertin Pharma (Biotec Centre, SPI-BIO and Ellipse Pharmaceuticals), with a current turnover over 10 M€ for 80 people, proposes to its clients a comprehensive range of products and services throughout the drug development process.

Group's workforce in 2008: 500 people with over 400 technical executives including pharmacists, bioscience PhDs, biochemists, biotechnology engineers.

Over 100 patents

Shareholders who ensure the independence of services and extensive development capability.

Reference shareholder: CNIM, Constructions Industrielles de la Méditérranée.